Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors

Rebecca Simpson(The University of Sydney), Erin R. Shanahan(The University of Sydney), Richard A. Scolyer(The University of Sydney), Georgina V. Long(The University of Sydney)

Nature Reviews Clinical Oncology

July 24, 2023

10.1038/s41571-023-00803-9

Cited by 132

Abstract

Related Papers

Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

Naiyer A. Rizvi, Matthew D. Hellmann, Alexandra Snyder et al.|Science|2015|7.9k

Enterotypes of the human gut microbiome

Manimozhiyan Arumugam, Jeroen Raes, Éric Pelletier et al.|Nature|2011|7.6k

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Paul C. Tumeh, Christina L. Harview, Jennifer H. Yearley et al.|Nature|2014|6.6k

Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes

Gary D. Wu, Jun Chen, Christian Hoffmann et al.|Science|2011|6.5k

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

Yukihiro Furusawa, Yuuki Obata, Shinji Fukuda et al.|Nature|2013|5.3k